Watchlist Price Alert

VolitionRx Limited (VNRX)

AMEX: VNRX · Real-Time Price · USD

0.52

0.00 (0.60%)

At close: May 23, 2025, 3:59 PM

0.51

-1.44%

After-hours: May 23, 2025, 05:05 PM EDT

0.60% (1D)

Bid	0.49
Market Cap	53.1M
Revenue (ttm)	1.31M
Net Income (ttm)	-24.02M
EPS (ttm)	-0.27
PE Ratio (ttm)	-1.91
Forward PE	-17.17
Analyst	Buy

Ask	0.53
Volume	180,162
Avg. Volume (20D)	223,723
Open	0.49
Previous Close	0.52
Day's Range	0.49 - 0.53
52-Week Range	0.40 - 0.90
Beta	1.00

About VNRX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol VNRX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VNRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

VolitionRx has released their quartely earnings on May 15, 2025:

Revenue of $246.38K misses estimates by $833.62K, with 43.64% YoY growth.

EPS of -0.06 misses estimates by -0.01, with 40.00% YoY growth.

Why Price Moved

1 month ago

+7.39%

VolitionRX shares are trading higher on possible c... Unlock content with Pro Subscription

9 months ago

-7.19%

VolitionRx shares are trading lower after the company announced the pricing of its $21.5 million registered direct offering.

News

1 week ago · seekingalpha.com

VolitionRX Limited (VNRX) Q1 2025 Earnings Call Transcript

VolitionRX Limited (NYSE:VNRX ) Q1 2025 Earnings Conference Call May 16, 2025 8:30 AM ET Company Participants Louise Batchelor – Chief Marketing and Communications Officer Terig Hughes – Chief Financi...

1 month ago · seekingalpha.com

VolitionRx Limited (VNRX) Q4 2024 Earnings Call Transcript

VolitionRx Limited (NYSE:VNRX ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Louise Batchelor - Chief Marketing & Communications Officer Cameron Reynolds - President...